EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 204 / Numéro 4 (2010) Biologie Aujourd'hui, 204 4 (2010) 295-300 Références
Accès gratuit
Numéro
Biologie Aujourd'hui
Volume 204, Numéro 4, 2010
Page(s) 295 - 300
Section Les chimiokines : de nouveaux messagers communs entre système nerveux et système immunitaire
DOI https://doi.org/10.1051/jbio/2010023
Publié en ligne 10 janvier 2011
  • Apartis E., Trocello J.M., Skrzydelski D., Mélik-Parsadaniantz S., Sorokine A., Kitabgi P., Rostène W., Changes in SDF-1/CXCR4 and MCP-1/CCR2 expression in the substantia nigra of the 6-hydroxydopamine-lesioned rat. Communication à la Société des Neurosciences. Mai 2005, Lille. [Google Scholar]
  • Banisadr G., Quéraud-Lesaux F., Boutterin M.C., Pélaprat D., Zalc B., Rostène W., Haour F., Parsadaniantz S.M., Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem, 2002a, 81, 257–269. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci, 2002b, 16, 1661–1671. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Skrzydelski D., Kitabgi P., Rostène W., Parsadaniantz S.M., Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain : constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci, 2003, 18, 1593–1560. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Gosselin R., Mechighel P., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Highly regionalized neuronal expression of MCP-1/CCL2 in rat brain. Evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol, 2005, 489, 275–292. [CrossRef] [PubMed] [Google Scholar]
  • Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A., CXCR4-activated astrocyte glutamate release via TNFalpha : amplification by microglia triggers neurotoxicity. Nat Neurosci, 2001, 4, 702–710. [CrossRef] [PubMed] [Google Scholar]
  • Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 1996, 382, 829–833. [CrossRef] [PubMed] [Google Scholar]
  • Brouard A., Pélaprat D., Dana C., Vial M., Lhiaubet A.M., Rostène W., Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. Neuroscience, 1992, 12, 1409–1415. [PubMed] [Google Scholar]
  • Callier S., Le Saux M., Lhiaubet A.M., Di Paolo T., Rostène W., Pélaprat D., Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture. J Neurochem, 2002, 80, 307–316. [CrossRef] [PubMed] [Google Scholar]
  • Cicchetti F., Brownell A.L., William K., Chen Y.I., Livni E., Isacson O., Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci, 2002, 15, 991–998. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., Rovère C., Rostène W., Mélik-Parsadaniantz S., Nahon J.L., Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones : presynaptic mechanisms. J Neurochem, 2006, 96, 1540–1550. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., Rovère C., Apartis E., Rostène W., Kitabgi P., Mélik-Parsadaniantz S., Nahon J.L., Stromal-cell-derived factor1alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci, 2008, 28, 862–870. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., De Giry I., Rovère C., Conductier G., Trocello J.M., Daugé V., Kitabgi P., Rostène W., Nahon J.L., Mélik-Parsadaniantz S., Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system : a novel mechanism for the control of dopamine release. Neuroscience, 2009, 15, 1072–1080. [CrossRef] [Google Scholar]
  • Hébert G., Arsaut J., Dantzer R., Demotes-Mainard J., Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci Lett, 2003, 349, 191–195. [CrossRef] [PubMed] [Google Scholar]
  • Hirsch E.C., Glial cells and Parkinson’s disease. J Neurol, 2000, 247, II/58–II/62. [Google Scholar]
  • Kaul M., Garden G.A., Lipton S.A., Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 2001, 410, 988–994. [CrossRef] [PubMed] [Google Scholar]
  • Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A., The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp Neurol, 1999, 156, 50–61. [CrossRef] [PubMed] [Google Scholar]
  • Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi, F., SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci, 2000, 12, 2497–2504. [CrossRef] [PubMed] [Google Scholar]
  • Lorenzl S., Albers D.S., Narr S., Chirichigno J., Beal M.F., Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson’s disease. Exp Neurol, 2002, 178, 13–20. [CrossRef] [PubMed] [Google Scholar]
  • Lorenzl S., Calingasan N., Yang L., Albers D.S., Shugama S., Gregorio J., Krell H.W., Chirichigno J., Joh T., Beal M.F., Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice. Neuromolecular Med, 2004, 5, 119–132. [CrossRef] [PubMed] [Google Scholar]
  • Meucci O., Fatatis A., Simen A.A., Miller R.J., Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA, 2000, 97, 8075–8080. [CrossRef] [Google Scholar]
  • McQuibban G.A., Butler G.S., Gong G.H., Bendall L., Power C., Clark-Lewis I., Overall C.M., Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem, 2001, 276, 43503–43508. [CrossRef] [PubMed] [Google Scholar]
  • Nagatsu T., Mogi M., Ichinose H., Togari A., Cytokines in Parkinson’s disease. J Neural Transm Suppl., 2000, 58, 143–51. [PubMed] [Google Scholar]
  • Oberlin E., Amara A., Bachèlerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature, 1996, 382, 833–835. Erratum in : Nature 1996, 384, 288. [CrossRef] [PubMed] [Google Scholar]
  • Pycock C.J., Turning behaviour in animals. Neuroscience, 1980, 5, 461–514. [CrossRef] [PubMed] [Google Scholar]
  • Skrzydelski D., Guyon A., Dauge V., Rovère C., Apartis E., Kitabgi P., Nahon J.L., Rostène W., Mélik-Parsadaniantz S., The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem, 2007, 102, 1175–1183. [CrossRef] [PubMed] [Google Scholar]
  • Valenzuela-Fernandez A., Planchenault T., Baleux F., Staropoli I., Le Barillec K., Leduc D., Delaunay T., Lazarini F., Virelizier J.L., Chignard M., Pidard D., Arenzana-Seisdedos F., Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem, 2002, 277, 15677–15689. [CrossRef] [PubMed] [Google Scholar]
  • Vila M., Jackson-Lewis V., Guégan C., Wu D.C., Teismann P., Choi D.K., Tieu K., Przedborski S., The role of glial cells in Parkinson’s disease. Curr Opin Neurol, 2001, 14, 483–489. [CrossRef] [PubMed] [Google Scholar]
  • Shimoji M., Pagan F., Healton E.B., Mochetti I., CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson’s disease. Neurotox Res, 2009, 16, 318–328. [CrossRef] [PubMed] [Google Scholar]
  • Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Hollenberg M.D., Jhamandas J.H., Overall C.M., Power C., Proteolytic processing of SDF-1a reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Nat Acad Sci USA, 2006, 103, 19182–19187. [Google Scholar]
  • Wightman R.M., Robinson D.L., Transient changes in mesolimbic dopamine and their association with “reward”. J Neurochem, 2002, 82, 721–35. [CrossRef] [PubMed] [Google Scholar]
  • Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C., HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nature Neurosci, 2003, 6, 1064–1070. [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.